Steigerwald, Gordon & Koch Inc. Eli Lilly & CO Transaction History

Steigerwald, Gordon & Koch Inc.

$803 Million
Q1 2024

A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 3,172 shares of LLY stock, worth $2.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

3,172

Previous 3,427 7.44%

Holding current value

$2.9 Million

Previous $2 Million 23.54%

% of portfolio

0.31%

Previous 0.27%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $151,011 - $202,031	-255 Reduced 7.44%	3,172 $2.47 Million
Q4 2023 Jan 16, 2024	BUY	$525.19 - $619.13 $91,908 - $108,347	175 Added 5.38%	3,427 $2 Million
Q3 2023 Oct 11, 2023	SELL	$434.7 - $599.3 $21,735 - $29,964	-50 Reduced 1.51%	3,252 $1.75 Million
Q2 2023 Jul 17, 2023	BUY	$350.74 - $468.98 $350 - $468	1 Added 0.03%	3,302 $1.55 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $79,210 - $93,029	-255 Reduced 7.17%	3,301 $1.13 Million

Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $53,698 - $62,569	-167 Reduced 4.49%	3,556 $0
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $13,638 - $15,542	-46 Reduced 1.22%	3,723 $1.2 Million
Q2 2022 Jul 14, 2022	BUY	$278.73 - $327.27 $168,074 - $197,343	603 Added 19.05%	3,769 $1.22 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $143,864 - $178,787	-613 Reduced 16.22%	3,166 $907,000
Q3 2021 Oct 18, 2021	SELL	$221.6 - $272.71 $15,512 - $19,089	-70 Reduced 1.82%	3,779 $873,000
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $45,680 - $59,136	-278 Reduced 6.74%	3,849 $719,000
Q4 2020 Jan 22, 2021	BUY	$130.46 - $172.63 $6,262 - $8,286	48 Added 1.18%	4,127 $697,000
Q3 2020 Oct 14, 2020	SELL	$146.22 - $169.13 $584 - $676	-4 Reduced 0.1%	4,079 $604,000
Q1 2020 Apr 20, 2020	BUY	$119.05 - $147.35 $92,620 - $114,638	778 Added 23.54%	4,083 $566,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $134,184 - $166,199	1,255 Added 61.22%	3,305 $434,000
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $2,562 - $2,787	-24 Reduced 1.16%	2,050 $229,000
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $55,395 - $64,660	-500 Reduced 19.43%	2,074 $230,000
Q1 2019 Apr 18, 2019	SELL	$111.31 - $131.02 $47,418 - $55,814	-426 Reduced 14.2%	2,574 $334,000
Q2 2018 Sep 14, 2018	SELL	$75.7 - $86.88 $22,710 - $26,064	-300 Reduced 9.09%	3,000 $256,000
Q1 2018 Sep 14, 2018	SELL	$74.21 - $87.6 $29,683 - $35,040	-400 Reduced 10.81%	3,300 $255,000
Q4 2017 Sep 14, 2018	BUY	$81.94 - $87.89 $303,178 - $325,193	3,700	3,700 $313,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.

Account

Steigerwald, Gordon & Koch Inc. Eli Lilly & CO Transaction History